期刊文献+

反相高效液相色谱法测定硫唑嘌呤代谢产物6-巯基嘌呤血浆药物浓度 被引量:2

Determination of 6-mercaptopurine in human plasma by RP-HPLC
下载PDF
导出
摘要 目的:建立反相高效液相色谱法(RP -HPLC)检测人血浆中硫唑嘌呤(AZA)代谢产物6-巯基嘌呤(6-MP)的浓度,为临床进行血药浓度监测提供基础。方法采用 Hypersil ODS2色谱柱(250 nm ×4.6 nm,5μm),流动相为乙腈-0.3%冰乙酸化(3∶97),流速为0.8 mL·min -1,检测波长323 nm,血浆样品经15%高氯酸去蛋白后加氢氧钠(NaOH)调节 pH 后20μL 进样分析。结果6-MP 血浆样品在0.02~2.00 mg·L -1范围内线性关系良好,最低检测下限(LLOQ)为0.02 mg·L -1;LLOQ、高浓度(1.5 mg·L -1)、中浓度(1 mg·L -1)和低浓度(0.05 mg·L -1)提取回收率分别为85.71%、92.93%、103.53%和96.02%,质控四个浓度的日内与日间精密度均<15.0%,符合中国药典生物样本分析相关规定。结论该实验成功建立一种简单、快速、高灵敏度的6-MP 血浆浓度测定方法,符合 AZA 血药浓度监测和药代动力学研究的相关规定。 Objective To establish a reversed phase high -performance liquid chromatography(RP -HPLC)method to determine 6-mercaptopurine (6-MP)in human plasma,thereby providing the foundation for clinical blood concentration monitoring.Methods U-sing Hypersil ODS2 column (250 nm ×4.6 nm,5 μm),the mobile phase was acetonitrile -0.3% glacial acetic acid (3∶97),the flow rate was 0.8 mL · min -1 ,the detection wavelength was set at 323 nm,and plasma samples were extracted by 20 μL 15% perchloric acid.Results A linearity was observed within the rangefrom 0.02 mg ·L -1 to 2.00 mg ·L -1 ,the lowest detection limit was 0.02 mg ·L -1 ,the average method recovery rate of four concentrations were 85.71%,92.93%,103.53% and 96.02%,respectively,and the intra -day and inter -day precision are 〈15% and in line with the Chinese Pharmacopoeia biological sample analysis regulations.Con-clusions The experiment successfully established a simple,fast,and low cost 6-MP plasma concentration measuring method with high sensitivity and good stability.Particularly,the method needs less blood.It is also in line with the relevant provisions of the AZA blood drug concentration monitoring and pharmacokinetics study.
出处 《安徽医药》 CAS 2016年第6期1081-1083,共3页 Anhui Medical and Pharmaceutical Journal
关键词 硫唑嘌呤 色谱法 反相 血药浓度 Azathioprine Chromatography,reverse-phase Plasma concentration
  • 相关文献

参考文献7

二级参考文献89

  • 1李方,叶启东,唐跃年,张顺国.高效液相色谱法测定人血红细胞内硫鸟嘌呤核苷酸浓度[J].中国药房,2006,17(6):438-440. 被引量:3
  • 2顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:472
  • 3马晓莉,吴敏媛,胡亚美,朱平,李志刚.巯嘌呤甲基转移酶基因多态性位点与酶活性的关系[J].中华肿瘤杂志,2006,28(6):456-459. 被引量:10
  • 4熊晖,熊磊,苏丹,辛华雯,吴笑春,李罄,李高.HPLC法检测人红细胞中巯嘌呤甲基转移酶的活性[J].中国药师,2007,10(8):738-740. 被引量:4
  • 5Meyer V,Beissert S.Azathioprine in the treatment of auto-immune blistering diseases[J].Immunology and Clinics of North America,2012,32(2):295.
  • 6Barrett G.Levesque,Edward V.Loftus.Initiating Azathio-prine for Crohn’s Disease[J].Clinical Gastroenterology and Hepatology,2012(10):460.
  • 7Andoh A,Tomoyuki T,Hiromitsu B,et al.Monitoring6-thioguantine concentrations in Japanese patients with in-flammatory bowel disease[J].Journal Gastroenterology and Hepatology,2008(23):1373.
  • 8Stocco G,Londero M,Campanozzi A,et al.Usefulness of the measurement of azathioprine metabolites in the assess-ment of non-adherence[J].Journal of Crohn’s and Colitis,2010(4):599.
  • 9Pozler O,Chladek J,Maly J,et al.Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease[J].Journal of Crohn’s and Colitis,2010(4):623.
  • 10Zabala FW, Barreiro AM, Echarri A, et al. A pharmacogenetics study of TPMT and ITPA genes detects a relationship with side effects and clinical response in patients with inflammatory bowel disease re- ceiving Azathioprine [ J ]. J Gastrointestin Liver Dis, 201J, 20 ( 3 ) : 247-253.

共引文献46

同被引文献12

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部